Common Contracts
2 similar Incentive Compensation Agreement contracts by Immucell Corp /De/
AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENTIncentive Compensation Agreement • March 29th, 2023 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances
This AMENDED AND RESTATED INCENTIVE COMPENSATION AGREEMENT, dated as of March 28, 2023, is by and between IMMUCELL CORPORATION, a Delaware corporation (the “Company”) and MICHAEL F. BRIGHAM (the “Executive”), and replaces and supersedes in its entirety the Incentive Compensation Agreement, dated as of March 28, 2022, between the Company and the Executive.
INCENTIVE COMPENSATION AGREEMENTIncentive Compensation Agreement • March 30th, 2022 • Immucell Corp /De/ • In vitro & in vivo diagnostic substances • Maine
This INCENTIVE COMPENSATION AGREEMENT, dated as of March 28, 2022, is by and between IMMUCELL CORPORATION, a Delaware corporation (the “Company”) and MICHAEL F. BRIGHAM (the “Executive”).
